isolation-brain-spinal-cord-mononuclear-cells-using-percoll

Isolation of Brain and Spinal Cord Mononuclear Cells Using Percoll Gradients

Isolation of immune cells that infiltrate the central nervous system (CNS) during infection, trauma, autoimmunity or neurodegeneration, is often required ...

In a recently developed mouse model for neurocysticercosis, the immune response was characterized by a massive influx of gammadelta T cells and a type 1 pathway of cytokine expression. To understand the role of gammadelta T cells during this infection, the cellular and cytokine response was analyzed in mice that lack gammadelta T cells (TCRdelta(-/-)). In TCRdelta(-/-) mice, Mesocestoides corti metacestodes preferentially invaded the extraparenchymal areas of the brain. Furthermore, parasites were able to escape from the brain and establish a systemic infection with liver and peritoneal involvement. Immunopathological studies indicated that TCRdelta(-/-) mice develop little inflammatory response and less neurological symptomatology. Significantly reduced numbers of T cells, macrophages, dendritic cells, and mast cells were present in the brain. The cytokine response in the brain of TCRdelta(-/-) mice appears to be a mixed type1/type 2 response with low levels of IL-2, IL-4, IL-10, IL-12, IL-13, IL-15, and IFN-gamma. To further investigate the immunological significance of this cell population, gammadelta T cells were adoptively transferred into intracranially infected TCRdelta(-/-) mice. gammadelta T cells were specifically recruited into the CNS in response to this parasitic infection, and they were able to target the infected brain within 12 h after transfer. These results suggest that gammadelta T cells are key players in the immune response elicited during this CNS infection and direct a type 1 response in wild-type mice upon infection.

Gamma/delta T cell-deficient mice exhibit reduced disease severity and decreased inflammatory response in the brain in murine neurocysticercosis.

Gamma / delta-T-Zell-defizienten M&#xE4;usen eine verringerte Schwere der Erkrankung und vermindert entz&#xFC;ndliche Reaktion im Gehirn in murinen Neurozystizerkose.

According to a previous report, the degree of the host immune response highly correlates with severity of the disease in the murine model for neurocysticercosis. In wild-type mice, Mesocestoides corti infection induced a rapid and extensive accumulation of gamma delta T cells and macrophages in the brain. NK cells, dendritic cells, alpha beta T cells, and B cells were also recruited to the brain but at lower levels. In contrast, gamma delta T-cell-deficient mice exhibited decreased cellular infiltration and reduced central nervous system (CNS) pathology. To understand the mechanisms of leukocyte recruitment into the CNS, chemokine expression was analyzed in infected brains in the present study. MCP-1 (CCL2), MIP-1 alpha (CCL3), and MIP-1 beta (CCL4) were up-regulated within 2 days after M. corti infection. Protein expression of RANTES (CCL5), eotaxin (CCL11), and MIP-2 was detected later, at 1 week postinfection. Correlating with the decreased cellular infiltration, delta chain T-cell receptor-deficient (TCR delta(-/-)) mice exhibited substantially reduced levels of most of the chemokines analyzed (with the exception of eotaxin). The results suggest that gamma delta T cells play an important role in the CNS immune response by producing chemokines such as MCP-1 and MIP-1 alpha, enhancing leukocyte trafficking into the brain during murine neurocysticercosis.

CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response.

CC-Chemokine vermitteln Leukozyten Handel in das zentrale Nervensystem im murinen Neurozystizerkose: Rolle der gamma delta T-Zellen in der Amplifikation der Immunantwort des Wirts.

Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.

Control of microglial neurotoxicity by the fractalkine receptor.

Mikroglia, die entz&uuml;ndlichen Zellen des ZNS, sind die einzigen CNS-Zellen, die den Fractalkine-Rezeptor (CX3CR1) Ausdr&uuml;cken. Anhand drei verschiedene in-vivo-Modelle zeigen wir, dass CX3CR1 Mangel Dysregulates Microglial Antworten, was zu Neurotoxizit&auml;t. Periphere Lipopolysaccharid-Injektionen zeigte Cx3cr1-/-M&auml;use Zelle-autonome Microglial Neurotoxizit&auml;t. Als toxische Modell der Parkinson-Krankheit und einer transgenen Modell der amyotrophen Lateralsklerose zeigte Cx3cr1-/-M&auml;use umfangreichere neuronale Zelle Verlust als Cx3cr1 + Littermate-Steuerelemente. Eine Verst&auml;rkung der CX3CR1 kann Signalisierung Microglial Neurotoxizit&auml;t, Schutz vor w&auml;hrend CNS Eindringen von pharmazeutischen CX3CR1 Antagonisten neuronale Anf&auml;lligkeit erh&ouml;hen k&ouml;nnte.

Kontrolle der Microglial Neurotoxizit&auml;t durch den Fractalkine-Rezeptor.

There is increasing interest in the isolation of adult microglia to study their functions at a morphological and molecular level during normal and neuroinflammatory conditions. Microglia have important roles in brain homeostasis, and in disease states they exert neuroprotective or neurodegenerative functions. To assay expression profiles or functions of microglia, we have developed a method to isolate microglial cells and infiltrating leukocytes from adult mouse brain. This protocol uses a digestion cocktail containing collagenase and dispase, and it involves separation over discontinuous percoll gradients. Isolated cells can be used for RNA analysis, including RNase protection analysis (RPA), quantitative RT-PCR, high-density microarray, proteomic or flow cytometric characterization of cell surface markers or adoptive transfer. Cell isolation can be completed in less than 4 h.

Isolation of murine microglial cells for RNA analysis or flow cytometry.

Gibt es zunehmende Interesse an der Isolierung der Erwachsenen Mikroglia, deren Funktionen auf molekulargenetischer und morphologischer Ebene w&auml;hrend Normal und neuroinflammatorische Bedingungen zu studieren. Mikroglia spielen eine wichtige Rolle im Gehirn Hom&ouml;ostase und in den Krankheitzust&auml;nden sie neuroprotektive oder Neurodegenerative Funktionen aus&uuml;ben. Zum Ausdruck-Profile oder Funktionen der Mikroglia Brutversuch, entwickelten wir eine Methode um Microglial Zellen und infiltrierendes Leukozyten aus adulten Maus Gehirn zu isolieren. Dieses Protokoll verwendet eine Verdauung cocktail mit Collagenase und Dispase, und es geht um die Trennung &uuml;ber diskontinuierliche Percoll Farbverl&auml;ufe. Isolierte Zellen eignet sich f&uuml;r RNA-Analyse, einschlie&szlig;lich RNase-Schutz-Analyse (RPA), quantitative RT-PCR, High-Density Microarray, Proteomic oder flie&szlig;en Cytometric Charakterisierung der Zelle Oberfl&auml;che Markierungen oder adoptiven Transfer. Zellenlokalisierung kann in weniger als 4 h abgeschlossen werden.

Isolierung von murinen Microglial Zellen f&uuml;r RNA-Analyse oder flie&szlig;en Cytometry.

Chemokines were detected by virtue of chemotactic effects toward neutrophils in the late 1970s. During subsequent decades, it has become clear that their primordial role in vertebrate biology was to facilitate organogenesis, with particularly important functions in the central nervous system (CNS). In common with other developmentally relevant factors, chemokines and their G-protein-coupled receptors continue to be expressed in the adult CNS as neuromodulators. In our progress toward chemokine receptor blockade for treatment of inflammatory and infectious diseases, the CNS physiology of the chemokine system will need to be a material consideration. In some cases, the dual functions of the chemokine system in the periphery and in the CNS offer unique possibilities for disease treatment.

Chemokines and chemokine receptors: multipurpose players in neuroinflammation.

Chemokine wurden in den sp&auml;ten 1970ern durch chemotaktische Effekte in Richtung Neutrophilen erkannt. In sp&auml;teren Jahrzehnten deutlich geworden, dass ihre herausragende Rolle in der vertebrate Biologie war Organogenese, mit besonders wichtigen Funktionen in das Zentralnervensystem (ZNS) zu erleichtern. Gemeinsam mit anderen entwicklungspolitisch relevanten Faktoren und weiterhin Chemokine und ihre G-Protein-gekoppelter Rezeptoren im Erwachsenen CNS als Neuromodulators ausgedr&uuml;ckt werden. Die CNS-Physiologie des Chemokin-Systems m&uuml;ssen in unsere Fortschritte in Richtung Chemokin-Rezeptor-Blockade zur Behandlung von entz&uuml;ndlichen und infekti&ouml;sen Erkrankungen eine materiell Erw&auml;gung sein. In einigen F&auml;llen bieten die dualen-Funktionen des Chemokin-Systems in der Peripherie und im ZNS einzigartige M&ouml;glichkeiten der Krankheitsbehandlung.

Chemokine und Chemokin-Rezeptoren: Mehrzweck Spieler in Neuroinflammation.

In vitro studies have implicated chemokine receptors in consumption and clearance of specific ligands. We studied the role that various signaling chemokine receptors play during ligand homeostasis in vivo. We examined the levels of ligands in serum and CNS tissue in mice lacking chemokine receptors. Compared with receptor-sufficient controls, Cx3cr1(-/-) mice exhibited augmented levels of CX3CL1 both in serum and brain, and circulating levels of CXCL1 and CXCL2 were increased in Cxcr2(-/-) mice. CCR2-deficient mice showed significantly increased amounts of circulating CCL2 compared with wild-type mice. Cxcr3(-/-) mice revealed increased levels of circulating and brain CXCL10 after experimental autoimmune encephalomyelitis (EAE) induction. CCR2-deficient peripheral blood and resident peritoneal cells exhibited reduced binding capacity and biologic responses to the CCR1 ligand CCL3, suggesting that elevated levels of CCR2 ligands had down-regulated CCR1. The results indicate that signaling chemokine receptors clear chemokines from circulation and tissues. These homeostatic functions of signaling chemokine receptors need to be integrated into safety and efficacy calculations when considering therapeutic receptor blockade.

Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues.

In vitro Studien haben Chemokinrezeptoren bei Verbrauch und Abfertigung spezifische Liganden beteiligt. Wir studierten die Rolle der verschiedenen Signalling Chemokinrezeptoren w&auml;hrend Ligand Hom&ouml;ostase in-vivo. Wir untersuchten des Liganden im Serum und CNS-Gewebe in M&auml;usen fehlt Chemokinrezeptoren. Verglichen mit der Rezeptor-ausreichende Kontrollen, Cx3cr1(-/-) M&auml;use stellte augmented Ebenen der CX3CL1 im Serum und Gehirn und zirkulierende Ebenen von CXCL1 und CXCL2 wurden bei Cxcr2(-/-) M&auml;usen erh&ouml;ht. CCR2-defizienten M&auml;usen zeigten deutlich erh&ouml;hte Mengen des zirkulierenden CCL2 im Vergleich zu Wildtyp M&auml;usen. Cxcr3(-/-) M&auml;usen ergab angestiegener im Umlauf und Gehirn CXCL10 nach experimentellen autoimmunen Enzephalomyelitis (EAE) Induktion. CCR2-defizienten peripherem Blut und Zellen mit peritoneal ausgestellt reduzierte Bindungskapazit&auml;t und biologischen Reaktionen auf den CCR1 Liganden CCL3, darauf hindeutet, dass erh&ouml;hte Konzentrationen von CCR2 Liganden unten-CCR1 geregelt hatte. Die Ergebnisse zeigen, dass die Signalisierung Chemokinrezeptoren Chemokine aus Zirkulation und Geweben deaktivieren. Diese hom&ouml;ostatischen Funktionen signalisieren Chemokinrezeptoren m&uuml;ssen in Sicherheit und Wirksamkeit Berechnungen integriert werden, wenn therapeutische Rezeptorblockade in Betracht.

Aufr&auml;umvorgang Rollen Chemokinrezeptoren: Chemokin-Rezeptor-Mangel umfassendere Ligand in Umlauf und Geweben zugeordnet ist.

Actions of chemokines and the interaction with specific receptors go beyond their original, defined role of recruiting leukocytes to inflamed tissues. Chemokine receptor expression in peripheral elements and resident cells of the central nervous system (CNS) represents a relevant communication system during neuroinflammatory conditions. The following examples are described in this review: Chemokine receptors play important homeostatic properties by regulating levels of specific ligands in blood and tissues during healthy and pathological conditions; chemokines and their receptors are clearly involved in leukocyte extravasation and recruitment to the CNS, and current studies are directed toward understanding the interaction between chemokine receptors and matrix metalloproteinases in the process of blood brain barrier breakdown. We also propose novel functions of chemokine receptors during demyelination/remyelination, and developmental processes.

Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation.

Aktionen-Familie und der Interaktion mit spezifischen Rezeptoren hinausgehen, ihre urspr&uuml;ngliche, definierte Rolle der Rekrutierung von Leukozyten auf entz&uuml;ndeten Gewebe. Chemokin-Rezeptor-Ausdruck in periphere Elemente und Zellen des zentralen Nervensystems (CNS) stellt ein System relevante Kommunikation w&auml;hrend neuroinflammatorische Bedingungen dar. In den folgenden Beispielen werden in diesem Bericht beschrieben: Chemokinrezeptoren spielen wichtige hom&ouml;ostatische Eigenschaften durch &Uuml;berwachung des Niveaus der spezifische Liganden in Blut und Gewebe bei gesunden und pathologischen Bedingungen; Chemokine und ihre Rezeptoren sind eindeutig in der Leukozyte Extravasation und die Rekrutierung von CNS verwickelt und aktuelle Studien auf ein Verst&auml;ndnis der Wechselwirkung zwischen Chemokinrezeptoren und Matrix Metalloproteinasen in den Prozess der Blut-Gehirn-Barriere-Aufschl&uuml;sselung ausgerichtet sind. Wir schlagen auch neuartige Funktionen Chemokinrezeptoren w&auml;hrend Demyelinisierung/Remyelination und Entwicklungsprozesse.

Chemokine innerhalb und au&szlig;erhalb des zentralen Nervensystems: viel mehr als Chemotaxis und Entz&uuml;ndungen.

Microglia, the primary immune effector cells in the brain, continually monitor the tissue parenchyma for pathological alterations and become activated in Alzheimer's disease. Loss of signaling between neurons and microglia via deletion of the microglial receptor, CX3CR1, worsens phenotypes in various models of neurodegenerative diseases. In contrast, CX3CR1 deficiency ameliorates pathology in murine stroke models. To examine the role of CX3CR1 in Alzheimer's disease-related Î²-amyloid pathology, we generated APPPS1 and R1.40 transgenic mouse models of Alzheimer's disease deficient for CX3CR1. Surprisingly, CX3CR1 deficiency resulted in a gene dose-dependent reduction in Î²-amyloid deposition in both the APPPS1 and R1.40 mouse models of AD. Immunohistochemical analysis revealed reduced staining for CD68, a marker of microglial activation. Furthermore, quantitative immunohistochemical analysis revealed reduced numbers of microglia surrounding Î²-amyloid deposits in the CX3CR1-deficient APPPS1 animals. The reduced Î²-amyloid pathology correlated with reduced levels of TNFÎ± and CCL2 mRNAs, but elevated IL1Î² mRNA levels, suggesting an altered neuroinflammatory milieu. Finally, to account for these seemingly disparate results, both in vitro and in vivo studies provided evidence that CX3CL1/CX3CR1 signaling alters the phagocytic capacity of microglia, including the uptake of AÎ² fibrils. Taken together, these results demonstrate that loss of neuron-microglial fractalkine signaling leads to reduced Î²-amyloid deposition in mouse models of AD that is potentially mediated by altered activation and phagocytic capability of CX3CR1-deficient microglia.

CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.

Mikroglia, die prim&auml;re immun Effektorzellen im Gehirn, kontinuierliche &Uuml;berwachung der Gewebe-Parenchym f&uuml;r pathologische Ver&auml;nderungen und bei Alzheimer-Krankheit aktiviert werden. Verlust der Signale zwischen Neuronen und Mikroglia durch L&ouml;schung des Microglial-Rezeptors, CX3CR1, verschlechtert Ph&auml;notypen in verschiedenen Modellen von neurodegenerativen Erkrankungen. CX3CR1-Mangel untergeordnete Pathologie in murinen Schlaganfall-Modelle. Um die Rolle der CX3CR1 in &beta;-Amyloid-Pathologie der Alzheimer-Krankheit mit Bezug zu untersuchen, haben wir APPPS1 und R1.40 transgener Mausmodelle der Alzheimer-Krankheit mangelhaft f&uuml;r CX3CR1 generiert. CX3CR1-Mangel f&uuml;hrte &uuml;berraschend eine gen dosisabh&auml;ngige Senkung &beta;-Amyloid-Ablagerungen in der APPPS1 und die R1.40 Maus-Modellen von AD. Immunohistochemical Analyse offenbart reduziert F&auml;rbung f&uuml;r CD68, eine Markierung der Microglial Aktivierung. Dar&uuml;ber hinaus verringerte quantitative Immunohistochemical Analyse offenbart Zahl der Mikroglia rund um &beta;-Amyloid-Ablagerungen in den APPPS1 CX3CR1-defizienten Tieren. Die reduzierte &beta;-Amyloid-Pathologie korreliert mit verminderter H&auml;ufigkeit TNF&alpha; und CCL2 mRNAs, aber erh&ouml;ht IL1&beta;-mRNA-Stufen, schl&auml;gt eine ver&auml;nderte neuroinflammatorische Milieu. Um diese scheinbar unvereinbare Ergebnisse ber&uuml;cksichtigen, schlie&szlig;lich brachten die in vitro und in-vivo-Studien Hinweise darauf, dass CX3CL1/CX3CR1 signalisieren die phagozytische Kapazit&auml;t der Mikroglia, einschlie&szlig;lich der Aufnahme von A&beta;-Fibrillen &auml;ndert. Zusammengenommen zeigen diese Ergebnisse, dass Verlust der Neuron-Microglial Fractalkine Signalisierung f&uuml;hrt zu reduzierten &beta;-Amyloid-Ablagerung in Mausmodelle der Anzeige, die potenziell von ver&auml;nderten Aktivierung vermittelt wird und phagozytische Funktion der CX3CR1-defizienten Mikroglia.

CX3CR1-Mangel ver&auml;ndert Microglial Aktivierung und Beta-Amyloid-Ablagerungen in zwei Modellen der Alzheimer-Krankheit-Maus reduziert.

Monocyte subpopulations distinguished by differential expression of chemokine receptors CCR2 and CX3CR1 are difficult to track in vivo, partly due to lack of CCR2 reagents.

Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice.

Monozyt Subpopulationen unterschieden durch differenzielle Expression von Chemokinrezeptoren CCR2 und CX3CR1 sind schwierig, in-vivo, teilweise durch mangelnde CCR2 Reagenzien zu verfolgen.

Selektive Chemokin-Rezeptor-Nutzung durch Zentralnervensystem myeloid Zellen CCR2-rot fluoreszierende Protein Knock-in M&auml;usen.

A microglial cell is both a glial cell of the central nervous system and a mononuclear phagocyte, which belongs to the haematopoietic system and is involved in inflammatory and immune responses. As such, microglia face a challenging task. The neurons of the central nervous system cannot divide and be replenished, and therefore need to be protected against pathogens, which is a key role of the immune system, but without collateral damage. In addition, after physical injury, neural cells need restorative support, which is provided by inflammatory responses. Excessive or chronic inflammatory responses can, however, be harmful. How microglia balance these demands, and how their behaviour can be modified to ameliorate disorders of the central nervous system, is becoming clear.

The myeloid cells of the central nervous system parenchyma.

We previously demonstrated a correlation between the frequency of CX3CR1-expressing human natural killer (NK) cells and disease activity in multiple sclerosis and showed that CX3CR1(high) NK cells were more cytotoxic than their CX3CR1(neg/low) counterparts. Here we aimed to determine whether human NK cell fractions defined by CX3CR1 represent distinct subtypes. Phenotypic and functional NK cell analyses revealed that, distinct from CX3CR1(high), CX3CR1(neg/low) NK cells expressed high amounts of type 2 cytokines, proliferated robustly in response to interleukin-2 and promoted a strong up-regulation of the key co-stimulatory molecule CD40 on monocytes. Co-expression analyses of CX3CR1 and CD56 demonstrated the existence of different NK cell fractions based on the surface expression of these two surface markers, the CX3CR1(neg) CD56(bright), CX3CR1(neg) CD56(dim) and CX3CR1(high) CD56(dim) fractions. Additional investigations on the expression of NK cell receptors (KIR, NKG2A, NKp30 and NKp46) and the maturation markers CD27, CD62L and CD57 indicated that CX3CR1 expression of CD56(dim) discriminated between an intermediary CX3CR1(neg) â€ƒCD56(dim) and fully mature CX3CR1(high) CD56(dim) NK cell fractions. Hence, CX3CR1 emerges as an additional differentiation marker that may link NK cell maturation with the ability to migrate to different organs including the central nervous system.

Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells.

Wir zuvor zeigte eine Korrelation zwischen der H&auml;ufigkeit der CX3CR1-Ausdruck menschlichen nat&uuml;rlichen killer (NK) Zellen und Krankheitsaktivit&auml;t bei multipler Sklerose und zeigten, dass CX3CR1(high) NK-Zellen mehr zytotoxisch als ihre CX3CR1(neg/low) Gegenst&uuml;cke waren. Wir sollen hier bestimmen, ob menschliche NK-Zelle-Br&uuml;che, die durch CX3CR1 definiert unterschiedliche Subtypen darstellen. Ph&auml;notypische und funktionelle Analysen der NK-Zelle ergab, dass Trennung von CX3CR1(high), CX3CR1(neg/low) NK-Zellen hohe Mengen an Typ-2-Zytokinen ausgedr&uuml;ckt, robust als Reaktion auf Interleukin-2 vermehren und eine starke bis-Regulierung des wichtigsten co-stimulatory Molek&uuml;ls CD40 auf Monozyten f&ouml;rderte. Koexpression Analysen von CX3CR1 und CD56 gezeigt die Existenz von verschiedenen NK-Zelle-Br&uuml;che, die basierend auf der Oberfl&auml;che Ausdruck dieser zwei Oberfl&auml;chen Marker, die CX3CR1(neg) CD56(bright), CX3CR1(neg) CD56(dim) und CX3CR1(high) CD56(dim) Br&uuml;che. Zus&auml;tzliche Untersuchungen zum Ausdruck der NK-Zell-Rezeptoren (KIR, NKG2A, NKp30 und NKp46) und die Reifung Marker CD27, CD62L und CD57 darauf hingewiesen, dass CX3CR1 Ausdruck des CD56(dim) zwischen einer zwischengeschalteten CX3CR1(neg) CD56(dim) und ausgereifte CX3CR1(high) CD56(dim) NK Zelle Br&uuml;che diskriminiert. Daher ergibt sich CX3CR1 als zus&auml;tzliche Differenzierung Marker, der Reifung der NK-Zelle mit der F&auml;higkeit, in verschiedene Organe, einschlie&szlig;lich des zentralen Nervensystems migrieren verkn&uuml;pfen kann.

Analysen der ph&auml;notypische und funktionelle Merkmale der CX3CR1-Ausdruck der nat&uuml;rlichen Killerzellen.

Microglial cells are difficult to track during development because of the lack of specific reagents for myeloid subpopulations. To further understand how myeloid lineages differentiate during development to create microglial cells, we investigated CX3CR1 and CCR2 transcription unit activation in Cx3cr1(+/GFP)CCR2(+/RFP) knockin fluorescent protein reporter mice. The principal findings include: 1) CX3CR1(+) cells localized to the aorta-gonad-mesonephros region, and visualized at embryonic day (E)9.0 in the yolk sac and neuroectoderm; 2) at E10.5, CX3CR1 single-positive microglial cells were visualized penetrating the neuroepithelium; and 3) CX3CR1 and CCR2 distinguished infiltrating macrophages from resident surveillant or activated microglia within tissue sections and by flow cytometric analyses. Our results support the contribution of the yolk sac as a source of microglial precursors. We provide a novel model to monitor chemokine receptor expression changes in microglia and myeloid cells early (E8.0-E10.5) in development and during inflammatory conditions, which have been challenging to visualize in mammalian tissues.

The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood.

Microglial Zellen sind schwierig, wegen des Mangels an spezifischer Reagenzien f&uuml;r myeloid Subpopulationen w&auml;hrend der Entwicklung zu verfolgen. Um noch besser zu verstehen wie myeloide Abstammungen w&auml;hrend der Entwicklung zum Erstellen Microglial Zellen unterscheiden, wir CX3CR1 und CCR2 Transkription Einheit Aktivierung in Cx3cr1(+/GFP)CCR2(+/RFP) knockin fluoreszierenden Proteins Reporter M&auml;use untersucht. Die wichtigsten Befunde sind: 1) CX3CR1(+) Zellen in der Aorta-Gonad-Urniere Region lokalisiert und visualisiert auf embryonale Tag (E) 9.0 im Dottersack und Neuroektoderm; 2) auf E10 wurden CX3CR1 Einzel-positiven Microglial Zellen visualisiert Durchdringung der Neuroepithelium; und 3) CX3CR1 und CCR2 unterschieden, Infiltration von Makrophagen aus resident Surveillant oder aktivierte Mikroglia im Gewebe Abschnitte und durch flie&szlig;en Cytometric Analysen. Unsere Ergebnisse unterst&uuml;tzen den Beitrag der Dottersack als Quelle von Microglial Grundstoffen. Wir bieten ein neuartiges Modell zur &Uuml;berwachung von Chemokin-Rezeptor Ausdruck &Auml;nderungen Mikroglia und myeloid Zellen fr&uuml;h (E8.0-E10) in der Entwicklung und bei entz&uuml;ndlichen Erkrankungen, die an wurde haben, um in den S&auml;ugetier-Geweben zu visualisieren.

Article	Year
Gamma/delta T cell-deficient mice exhibit reduced disease severity and decreased inflammatory response in the brain in murine neurocysticercosis. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 12218134	2002
CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response. Infection and immunity\| PubMed ID: 12704138	2003
Control of microglial neurotoxicity by the fractalkine receptor. Nature neuroscience\| PubMed ID: 16732273	2006
Isolation of murine microglial cells for RNA analysis or flow cytometry. Nature protocols\| PubMed ID: 17487181	2006
Chemokines and chemokine receptors: multipurpose players in neuroinflammation. International review of neurobiology\| PubMed ID: 17678962	2007
Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood\| PubMed ID: 18347198	2008
Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. Journal of leukocyte biology\| PubMed ID: 18467654	2008
CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. The American journal of pathology\| PubMed ID: 20864679	2010
Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PloS one\| PubMed ID: 21060874	2010
The myeloid cells of the central nervous system parenchyma. Nature\| PubMed ID: 21068834	2010
Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells. Immunology\| PubMed ID: 21320123	2011
The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 22079990	2012

Astrid E. Cardona

Biography

JoVE Journal Publications

Other Publications